Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...

Rivaroxaban tablets have several indications, including reducing the risk of stroke and systemic embolism in nonvalvular ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rivaroxaban Tablets ...

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 ...

Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood thinner ...

Obicetrapib provided dramatic reductions in LDL cholesterol, without noticeable side effects, in a phase III trial of ...

As ADHD and paediatric sleep disorders rise, French health authorities are calling for general practitioners to play a ...

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with atherosclerotic cardiovascular ...

Preventive antimigraine therapy (PAM) should probably not be considered until the headache frequency exceeds 1 per week. PAM is associated with significant side effects and often with ...